Grit Biotechnology
Clinical trials sponsored by Grit Biotechnology, explained in plain language.
-
Experimental cell injection targets Hard-to-Treat kidney diseases
Disease control Not yet recruitingThis early-stage trial tests a new cell therapy called GT719 in about 30 adults with immune-mediated kidney diseases such as IgA nephropathy and membranous nephropathy. The study aims to check the safety of the treatment and find the best dose. Participants receive a single injec…
Phase: EARLY_PHASE1 • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated May 26, 2026 06:40 UTC
-
Immune cells harvested from Patients' own tumors could fight advanced cancer
Disease control Not yet recruitingThis study tests an experimental therapy called GT307, made from a patient's own tumor-fighting immune cells. It is for people with advanced solid tumors (like cervical, melanoma, or lung cancer) that have spread or come back after standard treatment. The main goals are to see if…
Phase: NA • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated May 22, 2026 13:52 UTC